A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"Hashtag": "as:Hashtag"
}
],
"id": "https://social.heise.de/users/heiseonline/statuses/113482684206495803",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2024-11-14T18:19:00Z",
"url": "https://social.heise.de/@heiseonline/113482684206495803",
"attributedTo": "https://social.heise.de/users/heiseonline",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://social.heise.de/users/heiseonline/followers"
],
"sensitive": false,
"atomUri": "https://social.heise.de/users/heiseonline/statuses/113482684206495803",
"inReplyToAtomUri": null,
"conversation": "tag:social.heise.de,2024-11-14:objectId=9068861:objectType=Conversation",
"content": "<p>Erste Alzheimer-Therapie in EU zur Zulassung empfohlen</p><p>Allein in Deutschland leben mehr als eine Million Menschen mit Alzheimer. Einer Gruppe von Patienten könnte das Medikament Lecanemab helfen.</p><p><a href=\"https://www.heise.de/news/Erste-Alzheimer-Therapie-in-EU-zur-Zulassung-empfohlen-10036007.html?wt_mc=sm.red.ho.mastodon.mastodon.md_beitraege.md_beitraege&utm_source=mastodon\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">heise.de/news/Erste-Alzheimer-</span><span class=\"invisible\">Therapie-in-EU-zur-Zulassung-empfohlen-10036007.html?wt_mc=sm.red.ho.mastodon.mastodon.md_beitraege.md_beitraege&utm_source=mastodon</span></a></p><p><a href=\"https://social.heise.de/tags/Forschung\" class=\"mention hashtag\" rel=\"tag\">#<span>Forschung</span></a> <a href=\"https://social.heise.de/tags/Medizin\" class=\"mention hashtag\" rel=\"tag\">#<span>Medizin</span></a> <a href=\"https://social.heise.de/tags/Wissenschaft\" class=\"mention hashtag\" rel=\"tag\">#<span>Wissenschaft</span></a> <a href=\"https://social.heise.de/tags/news\" class=\"mention hashtag\" rel=\"tag\">#<span>news</span></a></p>",
"contentMap": {
"de": "<p>Erste Alzheimer-Therapie in EU zur Zulassung empfohlen</p><p>Allein in Deutschland leben mehr als eine Million Menschen mit Alzheimer. Einer Gruppe von Patienten könnte das Medikament Lecanemab helfen.</p><p><a href=\"https://www.heise.de/news/Erste-Alzheimer-Therapie-in-EU-zur-Zulassung-empfohlen-10036007.html?wt_mc=sm.red.ho.mastodon.mastodon.md_beitraege.md_beitraege&utm_source=mastodon\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">heise.de/news/Erste-Alzheimer-</span><span class=\"invisible\">Therapie-in-EU-zur-Zulassung-empfohlen-10036007.html?wt_mc=sm.red.ho.mastodon.mastodon.md_beitraege.md_beitraege&utm_source=mastodon</span></a></p><p><a href=\"https://social.heise.de/tags/Forschung\" class=\"mention hashtag\" rel=\"tag\">#<span>Forschung</span></a> <a href=\"https://social.heise.de/tags/Medizin\" class=\"mention hashtag\" rel=\"tag\">#<span>Medizin</span></a> <a href=\"https://social.heise.de/tags/Wissenschaft\" class=\"mention hashtag\" rel=\"tag\">#<span>Wissenschaft</span></a> <a href=\"https://social.heise.de/tags/news\" class=\"mention hashtag\" rel=\"tag\">#<span>news</span></a></p>"
},
"attachment": [],
"tag": [
{
"type": "Hashtag",
"href": "https://social.heise.de/tags/forschung",
"name": "#forschung"
},
{
"type": "Hashtag",
"href": "https://social.heise.de/tags/medizin",
"name": "#medizin"
},
{
"type": "Hashtag",
"href": "https://social.heise.de/tags/wissenschaft",
"name": "#wissenschaft"
},
{
"type": "Hashtag",
"href": "https://social.heise.de/tags/news",
"name": "#news"
}
],
"replies": {
"id": "https://social.heise.de/users/heiseonline/statuses/113482684206495803/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://social.heise.de/users/heiseonline/statuses/113482684206495803/replies?only_other_accounts=true&page=true",
"partOf": "https://social.heise.de/users/heiseonline/statuses/113482684206495803/replies",
"items": []
}
},
"likes": {
"id": "https://social.heise.de/users/heiseonline/statuses/113482684206495803/likes",
"type": "Collection",
"totalItems": 10
},
"shares": {
"id": "https://social.heise.de/users/heiseonline/statuses/113482684206495803/shares",
"type": "Collection",
"totalItems": 13
}
}